أثر تطبيق اتفاقية تريبس على براءة الاختراع الدوائية

Abstract EN

Developed countries sought to globalize the protection of their innovations within the framework of a multilateral trading system under the umbrella of the World Trade Organization (WTO) through the TRIPS Agreement.

This protection extended to the pharmaceutical industries through patent protection for 20 years, In addition to extending protection to both product and method.

This has negatively affected developing countries by acquiring the knowledge and innovations of developed countries in this sector by restricting the possibilities of manufacturing drugs for twenty years, which results in higher prices of these drugs and the monopoly of the major pharmaceutical companies in the pharmaceutical